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Abstract 
Adenomatoid Odontogenic Tumours (AOTs) are classified as benign epithelial odontogenic 
neoplasms with mature fibrous stroma, without odontogenic mesenchyme. However these lesions, 
like odontomes, occur almost exclusively during the final period of odontogenesis, and clinically 
behave like self-limiting hamartomatous lesions. Histologically they seem to arise from the lining of 
dental follicles. 
 
Null hypothesis 
The adenomatoid odontogenic tumour is a true neoplasm.  
  
Objective 
The aim of this study was to investigate the biological profile of the AOT by comparing the Ki-67 
proliferative indices of the AOT, Unicystic Ameloblastoma (UA) and Dentigerous Cyst (DC) using  
ImmunoRatio® software. 
 
Method  
Formalin-fixed and paraffin-embedded tissue blocks and routine-stained sections from 10 AOTs, 10 
UAs and 10 DCs were retrieved from the archive of the Department of Anatomical Pathology, 
Tygerberg Hospital, Cape Town, South Africa.  Immunohistochemical (IHC) staining of additional 
tissue sections was performed using the standard Avidin-Biotin Complex method. Ki-67 was 
detected using the monoclonal antibody MIB-1 (diluted 1:100, Dako, Carpinteria, CA, USA). 
 
Digital images of 10 selected high power fields of the IHC sections were captured using a BX41 
Olympus microscope. Each acquired image was submitted online for automated image analysis of 
Ki-67 immunostained tissue section using the ImmunoRatio® (Institute of Biomedical Technology, 
University of Tampere, Finland) software. The percentage of DAB-stained nuclei over the total 
nuclear area (DAB- and hematoxylin-stained) was calculated (proliferative index/PI).  The mean 
labeling index for each case and category was calculated using simple statistical analysis (R Core 
Team 2013). All statistical analysis was conducted in consultation with a statistician. 
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Results 
The mean proliferation indexes for DC, UA and AOT were respectively calculated as 10.403, 
10.406 and 4.757. 
 
Conclusion 
The considerably lower Ki-67 proliferation index for AOT confirms the limited growth potential of 
this odontogenic lesion and adds further support to its hamartomatous nature. Similar active 
proliferation indices for UA and DC could support the notion that dentigerous cysts may be 
regarded as benign cystic odontogenic neoplasms and should be treated accordingly. 
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Introduction 
 
The Adenomatoid Odontogenic Tumour (AOT) has quite a remarkable history due to the ongoing 
debate regarding its classification. Its basis for inclusion as an odontogenic tumour is the 
pathology’s exclusive location within the tooth-bearing region of the jaws and its histological 
resemblance to the dental organ. The AOT is not believed to be a true neoplasm and is known to 
be derived from odontogenic epithelium. It is characterised as having duct-like structures with 
varying degrees of inductive change in the connective tissue. (Kramer, Pindborg and Shear 1992). 
To this day, some believe it should be classified as an odontogenic tumour (Gardner 1978), an 
Adenomatoid Odontogenic Cyst (Marx and Stern 2003) and even a Hamartoma (Phillipsen and 
Reichart 1998). 
 
Radiographically, an AOT resembles both the  unicystic ameloblastoma (true neoplasm) and  
dentigerous cyst in young patients. The ameloblastoma is defined as "a benign but locally invasive 
polymorphic neoplasm consisting of proliferating odontogenic epithelium, which usually has a 
follicular or plexiform pattern, lying in a fibrous stroma" (Kramer, Pindborg and Shear 1992). The 
dentigerous cyst is defined as “a cyst which encloses the crown and is attached to the neck of an 
unerupted tooth. It is believed to develop by the accumulation of fluid between the reduced enamel 
epithelium and the crown of an unerupted tooth. It can also form between the layers of the reduced 
enamel epithelium" (Kramer, Pindborg and Shear 1992). Marx and Stern define the AOT as "a 
cystic hamartoma arising from odontogenic epithelium; it is characterised by an epithelium lined 
lumen, which proliferates to such an extent that it fills the entire luminal space, then mimicking a 
solid tumour".  Numerous authors have recently questioned the cystic nature of the AOT as  
bisection of the lesion indicated varying amounts of cystic change, proving that the tumour is often 
not entirely cystic (Gadewar and Srikant 2010).  
 
The proliferative index (PI)  may be used to determine the terminology/naming of the AOT with Ki-
67 as a marker. The aim of the test is to measure the rate at which the cells divide in the tumour. 
 
This will determine the classification of the AOT: true neoplasm, cyst or hamartoma, by comparing 
the PI (Ki-67 expression) in an AOT to that of a true neoplasm (such as the unicystic 
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ameloblastoma) and a true cyst (such as the dentigerous cyst). 
 
Null hypothesis 
The adenomatoid odontogenic tumour is a true neoplasm.  
 
Aim 
To compare the proliferative indices of the AOT, Unicystic Ameloblastoma (UA) and Dentigerous 
Cyst (DC) using immunohistochemical analysis with Ki-67.  
 
Objectives 
1. To evaluate the histopathological nature of the AOT 
      2.  To determine whether the AOT should be classified as a cyst, tumour or hamartoma. 
 
Ethical clearance 
Ethical clearance was obtained from the NHLS to carry out this retrospective study. Anonymity of 
all specimens was maintained. 
 
This research proposal was submitted to the Faculty and Senate Research Ethics Committee of 
the University of the Western Cape. Ethical clearance (clearance number 13/7/12) was obtained 
from the Research Ethics Committee of the University of the Western Cape.   
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1. Literature Review 
 
In the recent 2nd edition of the WHO "Histological Typing of Odontogenic Tumours''  (Kramer, 
Pindborg and Shear 1992) the Adenomatoid Odontogenic Tumour (AOT) has been defined as:   
"A tumour of odontogenic epithelium with duct-like structures and with varying degrees of inductive 
change in the connective tissue. The tumour may be partly cystic, and in some cases the solid 
lesion may be present only as masses in the wall of a large cyst. It is generally believed that the 
lesion is not a neoplasm." 
 
For over a century a specimen that meets the above diagnostic criteria has been diagnosed as an 
AOT. There have, however, been numerous attempts at accurately naming this pathological entity. 
In a review by Philipsen and Reichardt in 1998, the most likely first diagnosis of an AOT was that of 
Steensland in 1905 where he described the "Epithelioma Adamantinum". Initially, the AOT was 
considered to be a histological variant of the ameloblastoma. It was in 1965 that Philipsen and Birn 
reviewed 76 cases of AOTs that clearly distinguished it from the solid or multicystic 
ameloblastoma. Prior to this, the review article by Unal et al. in 1995 suggested that the AOT was a 
histological variant of the ameloblastoma. Names included "Adamantoma, Chorioblastomatous 
cyst, Adamantoblastoma, Adeno-ameloblastoma, simple Ameloblastoma, a pleomorphic adenoma-
like tumour within the wall of a dentigerous cyst, Adenomatoid Ameloblastoma, Adenomatoid 
Odontoma" (Rick 2004). 
 
Philipsen and Birn (1969) eventually proposed the name as we know it today, the Adenomatoid 
Odontogenic Tumour. The WHO histological typing of odontogenic tumours has retained this 
descriptive term.  
 
Epidemiology 
 
AOT accounts for approximately 3% to 7% of odontogenic tumours at institutions across the world 
and makes it the fourth most frequently occurring odontogenic tumour (Philipsen et al. 1991 and 
1998). In an article by Mohamed et al. in 2010, the demographics and incidences of AOTs amongst 
a sample of the South African population was reviewed between 1986 and 2006. 746 odontogenic 
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tumours were diagnosed, 33 of them were AOTs. The ages of the patients ranged from 9-37 years 
with an average age of 15 years. The 33 AOTs all occurred in rural/peri-urban areas of the 
northern region of South Africa. Thirty-two of the patients were younger than 30, and most of them 
were in their 20’s (Mohamed et al. 2010). The South African data appear to concur with the 
international indices for the AOT. 
 
In a review article by Philipsen et al in 1991 on AOTs, lesions were present in patients between the 
ages of 3 and 82. AOTs, however, occur more frequently in the second decade of life with 68.6% of 
all AOTs diagnosed in recent years being in patients in their twenties.  DCs, on the other hand, do 
not show any particular age bias and were diagnosed in patients ranging in age from 6-99 years 
(Zhang et al 2010). The UA seems to be diagnosed in much younger patients than its solid or 
multicystic counterpart (Ackermann et al, 1988). In the latter series, the mean age was 23.8 years 
(SD14.9) with 48% occurring in the second decade. A review article by Philipsen and Reichardt 
(1998) showed that the mean age of a patient at time of diagnosis of the UA correlated closely with 
the presence of an associated impacted tooth. 
 
Clinical Presentation 
 
The majority of AOTs occur in bone. They attach to the necks of unerupted teeth, surrounding the 
crowns and resembling a follicle (Jivan et al 2007).  However, some cases have shown no 
connection to unerupted teeth and have been reported to occur in the soft tissue extra-osseously 
(Philpsen et al 1992).  
 
Most central lesions are initially identified during routine dental radiography.  The delayed 
eruption of a permanent tooth or a slow-growing bony expansion (with or without displacement of 
adjacent teeth) that overlies the tumour commonly lead to the discovery of intragnathic AOTs.  
 
The classic signs of odontogenic tumours namely tooth mobility, facial asymmetry and cheek 
swelling, have been reported less frequently as presenting signs (Takahashi et al 2001). The 
peripheral variant can present as a gingival-coloured lesion that ranges from 1 to 1.5 mm in 
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diameter (Rick 2004). The peripheral variants of the AOT have ten times the propensity for 
maxillary gingiva than those of the mandible (Rick 2004). 
 
Location 
 
The AOT can be follicular, extrafollicular or peripheral. Extrafolllicular and follicular variants account 
for 96% of all AOTs and are intragnathic bony or central tumours. The follicular variant is three 
times more common than the extrafollicular type across genders. The lesion is found more 
commonly in the maxilla than in the mandible at a ratio of 2:1. The peripheral type occurs almost 
exclusively (88% of the time) in the anterior maxilla (Philipsen and Reichardt 1998). 
 
More often than not an unerupted or impacted tooth is associated with the AOT. The teeth showing 
least involvement with AOTs are unerupted first and second molars. The four canines account for 
59% of AOTs, 40% of those being maxillary. There seems to be no real relationship between 
central AOTs and unerupted deciduous teeth (Toida et al 1990). 
 
Radiology  
 
The AOT occurs as an intra-osseous as well as a peripheral lesion. Intrabony AOTs consist of 
follicular or extrafollicular types. The follicular type mimics a DC presenting as a unilocular 
radiolucency associated with the crown and they are initially diagnosed as dentigerous up to 77% 
of the time (Philipsen and Reichardt 1998). 
 
The extrafollicular type is found on the roots of unerupted teeth and has a well-defined unilocular 
radiolucency. Depending on the location of the lesion and the radiological similarities to other cysts 
usually found in these locations, they are often mistaken as residual, radicular, globulomaxillary or 
lateral periodontal cysts (Fig 1) (Philipsen and Reichardt 1998). 
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Fig 1. Distribution of pericoronal (dentigerous, follicular) 
AOT associated with unerupted permanent teeth (n = 341). 
(Data from Philipsen HP, Reichart PA. Adenomatoid 
odontogenic tumor: facts and figures. Oral Oncol 1998;35: 
125–31.) 
Approximately 65% of reported cases demonstrate faintly detectable radio-opacities within the 
cystic radiolucent lesion. In 1994, Dare et al illustrated that this feature is often not visible on 
panoramic films and it is thus advisable to obtain good quality periapical views of the area of 
suspected cases. With AOTs, divergence of roots and displacement of teeth occurs more 
frequently than root resorption (Fig 2 and 3) (Rick 2004). 
 
 
Fig 2. An extrafollicular radiolucent cyst-like lesion in the right parasymphyseal are. Note the root divergence, but absence of root resorption. 
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Fig 3. The same lesion showing the egg-shelled cortical bone with buccal expansion. 
 
 
Fig 4. A well-circumscribed extrafollicular radiolucent lesion associated with an upper canine. Note the divergence of the adjacent tooth roots. 
 Photo: Courtesy Prof CJ Nortje 
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Fig 5. AOT showing root divergence, note the absence of root resorption. Photo: Courtesy Prof CJ Nortje 
 
 
 
Fig 6.  A standard maxillary occlusal radiograph showing fine radiopaque changes within the intrafollicular lesion. Note the presence of impacted 
teeth and the displacement of the adjacent teeth. Photo: Courtesy Prof CJ Nortje 
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The peripheral AOT variant is usually similar in appearance to a gingival fibroma. It has also been 
likened to an epulis attached to the labial gingiva. In most cases plain radiographs do not detect 
any changes in the alveolar crest.  In some cases, the AOT can show erosion (Philipsen and 
Reichardt 1998). 
 
Macroscopic features 
 
On gross examination the macroscopic appearance of most excised surgical specimens of central 
AOTs reveal a soft, almost spherical mass surrounded with a thick fibrous capsule. Upon gross 
sectioning, the tumour may exhibit an exophytic-like epithelial lining (Fig 8). On occasion the 
proliferation will mask the cystic nature of the tumour. It is for this reason that Marx et al feel that 
the lesion is a cyst because it arises from the root sheet of Hertwig (Marx and Stern 2003). 
 
 
   Fig 7. Gross specimen of an excised AOT: Photo: Courtesy Prof CJ Nortje 
 
The lesion may occasionally appear as minimal yellow-brown fluid to semisolid material. It may 
also exhibit a white to tan, solid to crumbly tissue. There may even be one or more cystic spaces of 
varying size present.  It can be filled with a fine, hard gritty, granular material. One to several larger 
calcified masses may also be present (Fig 8) (Rick 2004).  
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Fig 8. An AOT displaying thick connective tissue wall and the exophytic epithelial lining growing into the lumen. Photo: Courtesy Prof CJ Nortje 
 
Histological features 
 
The AOT may be solid or there may be more or less extensive cyst formation. The epithelium 
typically shows plexiform strands. Sheets and rings of spindle cells are likely to be evident as well. 
The duct-like appearance is due to the rings of columnar cells.  However, these duct-like structures 
can be scanty. Between opposing rows of columnar cells there is often an acidophilic material that 
is usually Periodic Acid-Schiff positive. Immunohistochemical studies have shown this to be 
basement membrane-like material (Kramer, Pindborg and Shear 1992).  
 
Although most literature reviews contain multiple histochemical, ultrastructural and 
immunohistochemical analyses, these special tests are specifically required to establish a reliable 
diagnosis of the AOT. They have been almost exclusively used in research attempts to determine 
the cell of origin or the nature of the lesional products (Rick 2004). 
 
Two cases published by Raubenheimer et al in 1995 showed an association between UAs and 
AOTs.  In another study, Zeitoun et al in 1995 showed an AOT originating within a calcifying 
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odontogenic cyst (COC). They illustrated the transformation of the epithelial lining of a COC to form 
an AOT. Numerous other studies have subsequently shown an AOT and Calcifying Epithelial 
Odontogenic Tumour in combination. It is generally accepted that these are all histological variants 
of the AOT (Raubenheimer et al 1995; Matsumoto et al 2001; Zeitoun et al 1996 and Mosqueda-
Taylor et al 2005). 
 
Immunohistochemistry (IHC) 
 
In any neoplastic process, the cell cycle is a very important process where Cyclin-Dependent 
Kinases (CDKs) control the passage cycle. A group of proteins called CDK inhibitors that are 
present within the cycle, can block the activity of CDKs (Suzuki and Hashimoto, 2005). 
 
The Ki-67 protein (also known as MKI67) is associated with cellular proliferation and it is a 
distinctive marker that illustrates the rate at which cells proliferate. It is present in all active phases 
of the cell cycle. These include: G1, S, G2, and mitosis. During interphase, Ki-67 is found in the cell 
nucleus, whereas in mitosis it can be found on the surface of the chromosomes. It is not present in 
resting (G0). 
 
Numerous immunohistochemical studies have examined Keratocystic Odontogenic Tumours 
(KCOTs) by using different markers. These markers were specific for rate of proliferation and 
apoptosis. Ki-67 has been used in numerous studies as a marker of cell proliferation. The Ki-67 
antigen is present in the entire cell cycle and its level is shown to increase during the s-phase. 
Studies comparing KCOTs and dentigerous cysts have indicated the epithelial lining in the KCOT 
as having a higher proliferative potential than ameloblastomas. Ki-67 cells were most commonly 
found in the suprabasal layers of the cyst epithelium, whereas they were shown to be more in the 
epithelial linings of the KCOTs compared to other inflammatory cysts (Mendes 2011; Li et al 1995; 
Thosaporn et al 2004). 
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2. Materials and Methods 
 
Formalin-fixed and paraffin-embedded tissue blocks and routine-stained sections from 10 AOTs, 10 
UAs and 10 DCs were retrieved from the archive of the Department of Anatomical Pathology, 
Tygerberg Hospital, Cape Town, South Africa.  Immunohistochemical (IHC) staining of additional 
tissue sections was performed using the standard Avidin-Biotin Complex method. Ki-67 was 
detected using the monoclonal antibody MIB-1 (diluted 1:100, Dako, Carpinteria, CA, USA).  Digital 
images of 10 selected high power fields (HFP) of the IHC sections were captured using a BX41 
Olympus microscope. Each acquired image was submitted on-line for automated image analysis of 
Ki-67 immunostained tissue section using the ImmunoRatio® (Institute of Biomedical Technology, 
University of Tampere, Finland) software. The percentage of DAB-stained nuclei over the total 
nuclear area (DAB- and hematoxylin-stained) was calculated (proliferative index).   
 
Inclusive criteria which were examined by two observers were the existence of enough epithelial 
lining in the UA and DC, and the duct-like rosette structures in the AOT (Figs 8, 9 and 10). 
Specimens that had significant inflammation were excluded, as inflammation destroys the 
architecture of tumours, exaggerates tumoral dysplasia and falsely increases the PI in affected 
areas. 
 
Data were analyzed using a standardised statistical programme (R Core Team 2013) and captured 
on a Microsoft Excel® data sheet. Statistical analysis was conducted in consultation with a 
statistician. 
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3. Results 
  
 
Fig 9. Histological features of UA showing a very thin layer of odontogenic epithelium, with an epithelial island in the underlying connective tissues. 
Note the positively stained nucleus in active cells (red arrows) 
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Fig 10. Histological features of DC showing a non-keratinised stratified squamous epithelium derived from reduced enamel epithelium. Note the 
positively stained nucleus in active cells (red arrows) 
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Fig 11. Histological features of AOT showing large pseudo-ductular structures and rosettes. Note the positively stained nucleus in active cells (red 
arrows) 
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After reviewing the data and the spreadsheet for the 300 photomicrographs, the analysis was 
based on the following assumptions: (a) that there was no significant ordering of the 10 slides 
whose data were labelled a to j in the data spreadsheet (Appendix 1), and (b) that the mean of the 
slide values of a specimen was an appropriate representation of its PI.  
 
Assumption (a) was supported by Figure 12, a plot of individual slide values using different 
symbols for AOT, DC, UA, and Figure 13, a plot of means per type. Neither plot exhibited trends 
that clearly departed from randomness. 
 
Fig 12. A plot of individual slide values using different symbols for AOT, DC and UA 
 
 
 
 
UA 
DC 
AOT 
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Fig 13. A plot of means per type.  
 
 
For convenience the mean of the PI values over slides was called Y. There were 30 values of Y, 10 
for each type:  AOT, DC and UA.  Table 1 supplies some details on Y. 
 
Table 1: Summary statistics variable Y 
 
Mean Median SD Min Max 
AOT 4.757 4.735 1.749 2.18 7.8 
DC 10.508 8.06 6.810 4.47 24.5 
UA 10.406 6.005 12.234 3.57 44.01 
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Figure 14. Boxplots of variable Y for the AOT, DC and UA. 
  
Figure 14 indicates that the mean PI of type AOT was smaller than the means of the other two 
types. The dispersion of PI for AOT was also clearly smaller than that of the other two types. There 
appeared to be on outlier in type UA, but it was not eliminated. These trends were also clear in 
Table 1. 
 
To examine the statistical significance of the apparent differences in location of the three 
pathologies, some form of one-way analysis of variance is commonly used.  One of the most 
important requirements for applicability of the ANOVA-test is homogeneity of the variances of the 
three groups. According to a Bartlett test, the variances are significantly different (Bartlett's K-
squared = 22.4876, df = 2, p-value <0.0001). Transforming the Y values to loge(Y) has the effect of 
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stabilizing the variances (Bartlett's K-squared = 3.4415, df = 2, p-value = 0.1789).  Table 2 gives 
summary statistics of variable loge(Y). 
 
 
Table 2: Summary statistics variable loge(Y) 
 
Mean Median SD Min Max 
AOT 1.493 1.551 0.396 0.779 2.054 
DC 2.191 2.082 0.577 1.497 3.199 
UA 1.998 1.792 0.761 1.273 3.784 
 
The next step was to perform a one-way ANOVA using the loge(Y) values; the result was F-
statistic: 3.644 on 2 and 27 DF, p-value: 0.03973, indicating statistically significant differences 
between the means. The mean of AOT was significantly smaller than that of DC (p-value=0.015); 
the mean of AOT was marginally significantly different from that of UA (p-value=0.069). The means 
of DC and UA did not differ significantly. 
 
An alternative to the usual ANOVA as applied to either the original values or to some 
transformation of these values, like a logarithmic transformation, is to perform an analysis based on 
ranks. The Kruskal-Wallis test is rank-based. The result of applying this test to Y was: Kruskal-
Wallis chi-squared = 6.8361, df = 2, p-value = 0.03278, thus confirming the result of the ANOVA of 
loge(Y). 
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4. Discussion 
 
In a survey by Leon et al. (2005), the Ki-67 IHC marker was evaluated in 39 AOT cases. The 
expression of this marker was very low in AOTs (PI<1%) which led the investigators to conclude 
that this tumour grows very slowly and that it cannot invade adjacent tissues. 
 
In 2005 Barboza et al. applied Proliferative Cell Nuclear Antigen (PCNA)  and P53 markers in 16 
cases of solid ameloblastomas (SAB) and eight cases of AOTs. PCNA is a known marker for 
mitosis activity and is very similar to Ki-67. P53 is another marker that indicates proliferative and 
anti-apoptotic activities. Both markers were higher in SABs compared to AOTs (Barboza et al. 
2005). Barboza further concluded that SABs were more aggressive than AOTs after levels of Bcl-2 
and Ki-67 were evaluated in SABs and AOTs.  
 
The expression of Ki-67 is higher in the epithelial linings of Keratocystic Odontogenic Tumours 
(KCOTs) when compared to other developmental and inflammatory cysts (Mendes, Carvalho, Van 
Der Waal, 2011). For this reason Ki-67 was used to compare proliferative indices in the AOT, UA  
and the DC. The aim was to shed light on the actual characteristics of the AOT by comparing it to a 
true neoplasm such as the UA and a true cyst such as the DC. Tuominen et al developed 
Immunoratio® in 2010. They described an image analysis application, which is a user-friendly tool 
to assess Ki-67 proliferative indexes in hematoxylin-counterstained tissue sections. ImmunoRatio® 
analysis is based on defining positively stained pixel counts, which, according to their calibration 
data, correlates very well with cell nuclei enumerated visually. 
 
Ki-67 is a proliferation marker specific to mitoses and is never found in the non-proliferative phase 
of the cell cycle. This makes it an ideal marker for measuring tumour growth. Aggressive tumours 
have the ability to invade healthy surrounding tissues. The higher the PI, the more likely a tumour 
is to invade. 
 
Many studies in the scientific literature examine the histological basis of the AOT (Aritoba et al. 
1997, Greer 1997, Mohamed et al. 2010). Others examine histological evidence of induction (Jivan 
et al 2008). In other studies arguments were put forward regarding whether or not the AOT is 
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indeed a tumour, hamartoma or cyst (Otero et al 2009, Marx and Stern 2003, Garg et al 2008, 
Gadewar and Srikant, 2010).  
 
The basis of this study was to evaluate the PI for the three distinctly different pathologies. All three, 
however occur in similar parts of the jaws and have a similar radiological appearance. They also 
occur in a similar age group. The proliferation marker Ki-67 made it possible to measure the rate of 
growth for each of these pathologies and compare them to one another.  
 
The AOT is characterised by numerous pseudo-ductular structures of varying size which consist of 
a single layer of palisaded columnar non-secreting cells surrounding a central lumen. It is in these 
pseudo-ductular areas where most of the cellular proliferation takes place. It is exactly here (as 
seen in Figure 9) that most of the lesion’s growth takes place. The linings found within UA can 
classically have three different variants as described by Ackermann, Altini and Shear (1988). 
Group 1 lesions usually have a non-descript thin epithelial lining. Group 2 show intraluminal 
epithelial thickening and Group 3 show downward epithelial growth into the cyst wall or epithelial 
islands within the wall. All these areas showed positively stained nucleii with Ki-67. The DC cyst 
proved to be the most difficult pathology to source as only non-inflamed specimens had to be used 
for the study. Acute inflammation proved to increase the PI and would invariably distort the results. 
 
Measuring the PI can be a laborious process. Previously most studies counted the total number of 
positively stained cells and divided that figure by 1000. This process was undertaken by three 
different examiners to exclude intra- and inter-examiner variability. With Immunoratio® (Institute of 
Biomedical Technology, University of Tampere, Finland) this study was able to use an 
internationally accepted, standardised method of measuring PI (Tuominen et al 2010). This 
excluded the need for multiple examiners as photomicrographs were uploaded and PIs were 
attained for each of the HPFs that were taken (Figures 8, 9 and 10).  
 
The mean proliferation indices for DC, UA and AOT were respectively calculated as 10.508, 10.406 
and 4.757 (Table 1). The mean of AOT is significantly smaller than that of DC 
(p-value = 0.015); the mean of AOT is borderline significantly different from that of UA (p-value = 
0.069). The means of DC and UA do not differ significantly (Table 2).  
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There is a significant difference in PI of AOTs compared to DCs.  The DC also grows at a faster 
rate than the AOT.  In addition, the limited growth potential of the AOT is also apparent when 
compared to the UA.  This led the researchers to question why the AOT is considered a neoplasm 
while the DC is considered a cyst.  
 
However AOTs, like odontomes, occur almost exclusively during the final period of odontogenesis, 
and clinically behave like self-limiting hamartomatous lesions. Therefore, if one considers the 
reclassification of KCOTs by the WHO where Ki-67 expression is higher in the epithelial linings of 
KCOTs in comparison to other developmental and inflammatory cysts, and if a cystic neoplasm like 
the UA has a significantly higher PI than the AOT, then the AOT could be considered to be a cystic 
hamartoma arising from odontogenic epithelium, rather than a true neoplasm.   
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Conclusion 
 
The considerably lower Ki-67 proliferation index for the AOT confirms the limited growth potential of 
this odontogenic pathology and adds further support to its hamartomatous nature. Similar active 
proliferation indices for UAs and DCs could support the notion that dentigerous cysts may be 
regarded as benign cystic odontogenic neoplasms and should be treated accordingly. 
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Appendix A 
Table of results 
 
Slide a b c d e f g h i j Total Average 
28295 29.6 18.5 14.7 13.8 21.2 24.3 34.2 21.1 11 12.6 201 20.1 
A22666 19.9 7.1 14.4 16.9 58.6 33 48 20.4 17.5 9.2 245 24.5 
B22666 4.9 5.5 6.1 6 7.4 5.3 6.3 7.5 5.2 3.9 58.1 5.81 
5092 6.9 6.8 6.2 10.5 12 11.2 15.6 5.3 6.6 7.6 78.2 7.82 
6532 6 4.8 9.7 4 7 7.4 6.2 12.7 4.1 10.6 72.5 7.25 
6664 13.6 16.9 9.4 18.8 10.6 8.3 12 16.6 15.8 13.8 135.8 13.58 
6981 5.4 7.8 3.2 5.1 5.3 4.4 4.3 9 0 4.8 49.3 4.93 
12536 8.6 9.3 3.2 4.4 3.3 4.1 4.1 2.2 2.4 3.1 44.7 4.47 
8400 7.9 12.2 6 9.2 6.9 15.9 10.4 9.6 7.6 3.1 88.8 8.88 
18347 5.6 2.9 9.7 5.8 4.5 4.9 9.5 12.8 4.8 6.4 66.9 6.69 
12545 1.9 3.9 2.8 5.7 4.8 4.7 2.5 2.1 5.7 1.6 35.7 3.57 
12770 69.5 4.7 33 48.4 55.6 87.7 53.5 8.7 34 45 440.1 44.01 
13889 17.4 10.3 8.4 11.2 4.1 8.6 4.3 7.9 8.7 14.4 95.3 9.53 
13889-5 3.9 5.2 4.1 14.4 3.2 5.5 6.2 4.8 6 5.5 58.8 5.88 
10688 6.2 6.8 7.9 6.7 5.3 5.7 5 5.3 3.8 8.6 61.3 6.13 
8607 2.5 2.6 3.1 3.5 5 19.6 8.2 9.8 8.1 14 76.4 7.64 
3854 4.1 3.3 2.5 1.7 1.5 2.7 3.3 1.9 3.1 13.2 37.3 3.73 
4512 3.3 5.1 3.3 9.1 2.5 3.7 3.7 3.8 4.1 2.1 40.7 4.07 
7162 4.3 4.8 7.5 4 6.5 10.4 4.6 4.4 4.6 2.6 53.7 5.37 
19455 13.9 15.1 24.6 10.6 7.2 7.1 15.3 16.3 20.3 10.9 141.3 14.13 
EPA2858 4.7 7.4 4.2 3.8 4.1 4.9 4.8 7.8 5.3 6.9 53.9 5.39 
6503 4.2 4.5 5.5 3.7 3.3 4.9 4.9 3.4 5 3.9 43.3 4.33 
7912 4.5 7.3 10.1 5.5 17.9 6 6.9 4.9 7.6 7.3 78 7.8 
18698 4.1 5.3 4.8 6 3.9 3.9 5 11.5 8.4 4.5 57.4 5.74 
18912 1.7 6.8 4.9 1.9 1.7 2 3 1.8 2 1.4 27.2 2.72 
19342 3.8 3.4 5.2 4.5 4.8 4.2 3.9 2.5 3.7 2.6 38.6 3.86 
15404 2.3 7.2 2.9 24 2.4 1.9 3.4 1.9 2.2 3.2 51.4 5.14 
17932 3.6 2.7 3.2 3.1 4.1 4.4 4.6 2.8 4.3 4.1 36.9 3.69 
9783 1.7 2.3 2.5 2 3 2 2 2.8 1.8 1.7 21.8 2.18 
12148 7.8 8.9 3.5 8.3 6.3 5.9 9.9 7.8 2.2 6.6 67.2 6.72 
 
 
 
 
 
 
 
 
 
